Published in Vaccine Weekly, July 27th, 2005
Valeant has a strong presence in these regions and will begin distributing Botox in Hungary in July 2005 and in Poland in September 2005. Detailed terms of the agreement were not disclosed.
"Valeant is a company focused on neurology, infectious disease and dermatology with commercial strength in central and eastern Europe," Valeant's president and chief executive officer, Timothy C. Tyson said.
Valeant Pharmaceuticals International is a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.